1. Home
  2. BYON vs IGMS Comparison

BYON vs IGMS Comparison

Compare BYON & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYON
  • IGMS
  • Stock Information
  • Founded
  • BYON 1997
  • IGMS 1993
  • Country
  • BYON United States
  • IGMS United States
  • Employees
  • BYON N/A
  • IGMS N/A
  • Industry
  • BYON Catalog/Specialty Distribution
  • IGMS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYON Consumer Discretionary
  • IGMS Health Care
  • Exchange
  • BYON Nasdaq
  • IGMS Nasdaq
  • Market Cap
  • BYON 332.6M
  • IGMS 348.5M
  • IPO Year
  • BYON N/A
  • IGMS 2019
  • Fundamental
  • Price
  • BYON $9.01
  • IGMS $1.59
  • Analyst Decision
  • BYON Buy
  • IGMS Hold
  • Analyst Count
  • BYON 10
  • IGMS 8
  • Target Price
  • BYON $17.00
  • IGMS $6.14
  • AVG Volume (30 Days)
  • BYON 3.1M
  • IGMS 910.9K
  • Earning Date
  • BYON 02-24-2025
  • IGMS 03-06-2025
  • Dividend Yield
  • BYON N/A
  • IGMS N/A
  • EPS Growth
  • BYON N/A
  • IGMS N/A
  • EPS
  • BYON N/A
  • IGMS N/A
  • Revenue
  • BYON $1,476,271,000.00
  • IGMS $2,918,000.00
  • Revenue This Year
  • BYON N/A
  • IGMS $26.85
  • Revenue Next Year
  • BYON $4.55
  • IGMS $125.17
  • P/E Ratio
  • BYON N/A
  • IGMS N/A
  • Revenue Growth
  • BYON N/A
  • IGMS 57.64
  • 52 Week Low
  • BYON $4.45
  • IGMS $1.37
  • 52 Week High
  • BYON $37.10
  • IGMS $22.50
  • Technical
  • Relative Strength Index (RSI)
  • BYON 63.90
  • IGMS 19.44
  • Support Level
  • BYON $7.26
  • IGMS $1.37
  • Resistance Level
  • BYON $9.78
  • IGMS $1.59
  • Average True Range (ATR)
  • BYON 0.95
  • IGMS 0.16
  • MACD
  • BYON 0.25
  • IGMS 0.19
  • Stochastic Oscillator
  • BYON 81.80
  • IGMS 11.67

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad range of products, including furniture, décor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

About IGMS IGM Biosciences Inc.

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.

Share on Social Networks: